CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findings A follow-up Phase 3 study will be discussed with regulatory authorities LUND, Sweden, June 18, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced topline...
Hence then, the article about camurus positano study shows treatment effects with cam2029 in polycystic liver disease patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients )
Also on site :
- Five killed in helicopter crash on Africa’s highest mountain (VIDEO)
- transcosmos and V, Inc. launch metaverse creator services for VRChat via Geek Jack, transcosmos's cross-border e-commerce site for entertainment items
- The Christmas Day Storm